Attached files
| file | filename |
|---|---|
| EX-23.1 - CONSENT - Innovation Pharmaceuticals Inc. | ctix_ex231.htm |
| EX-31.1 - CERTIFICATION - Innovation Pharmaceuticals Inc. | ctix_ex311.htm |
| EX-32.2 - CERTIFICATION - Innovation Pharmaceuticals Inc. | ctix_ex322.htm |
| EX-31.2 - CERTIFICATION - Innovation Pharmaceuticals Inc. | ctix_ex312.htm |
| 10-K - FORM 10-K - Innovation Pharmaceuticals Inc. | ctix_10k.htm |
EXHIBIT 32.1
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
(Subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code)
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), the undersigned officer of Cellceutix Corporation, a Nevada corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
· The Annual Report on Form 10-K for the fiscal year ended June 30, 2015 of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and · the information contained in the Annual Report on Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: September 11, 2015 | By: | /s/ Krishna Menon |
|
|
|
| Krishna Menon |
|
|
|
| President and Director |
|